CALVIGIONI, MARCO
 Distribuzione geografica
Continente #
EU - Europa 170
NA - Nord America 101
AS - Asia 34
AF - Africa 8
Totale 313
Nazione #
IT - Italia 112
US - Stati Uniti d'America 101
SG - Singapore 23
DE - Germania 10
PL - Polonia 10
FR - Francia 7
GB - Regno Unito 7
AT - Austria 5
CI - Costa d'Avorio 5
HK - Hong Kong 5
SE - Svezia 5
BE - Belgio 4
BG - Bulgaria 3
CH - Svizzera 3
IE - Irlanda 2
IN - India 2
NG - Nigeria 2
PH - Filippine 2
FI - Finlandia 1
JP - Giappone 1
RU - Federazione Russa 1
SN - Senegal 1
VN - Vietnam 1
Totale 313
Città #
Milan 29
Pisa 24
New York 18
Ashburn 15
Frankfurt am Main 8
Chandler 7
Rome 7
Warsaw 7
London 6
Abidjan 5
Hong Kong 5
Seattle 5
Serra 5
Vienna 5
Marseille 4
Schaarbeek 4
Singapore 4
Florence 3
Livorno 3
Sofia 3
Żyrardów 3
Antony 2
Brookings 2
Cambridge 2
Dublin 2
Houston 2
Lagos 2
Lucca 2
Lumino 2
Pune 2
Taranto 2
Valenzuela 2
Bern 1
Boardman 1
Bremen 1
Columbus 1
Dakar 1
Fairfield 1
Kilburn 1
Lappeenranta 1
Lawrence 1
Lecco 1
Los Angeles 1
Marino 1
Medford 1
Messina 1
Nagold 1
Novosibirsk 1
Otemae 1
Palaiseau 1
Palermo 1
Perano 1
Pietrasanta 1
Pistoia 1
Princeton 1
Torre del Lago Puccini 1
Verona 1
Wilmington 1
Woodbridge 1
Totale 219
Nome #
A novel 3D in vitro model of the human gut microbiota 79
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice 76
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 43
Designs and methodologies to recreate in vitro human gut microbiota models 33
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 28
HPLC-MS-MS quantification of short-chain fatty acids actively secreted by probiotic strains 19
A Millifluidic Chamber for Controlled Shear Stress Testing: Application to Microbial Cultures 19
Analysis of the microbial content of probiotic products commercialized worldwide and survivability in conditions mimicking the human gut environment 15
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury 14
Development of an In Vitro Model of the Gut Microbiota Enriched in Mucus-Adhering Bacteria 12
Impact of Bacillus cereus on the Human Gut Microbiota in a 3D In Vitro Model 11
Animal and In Vitro Models as Powerful Tools to Decipher the Effects of Enteric Pathogens on the Human Gut Microbiota 8
Anti-Staphylococcal Biofilm Effects of a Liposome-Based Formulation Containing Citrus Polyphenols 3
Totale 360
Categoria #
all - tutte 1.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 3 7 0 0 0 4 1
2021/202210 0 0 0 0 3 1 0 0 1 0 3 2
2022/2023110 3 3 2 2 11 7 1 11 32 10 17 11
2023/2024225 13 17 36 21 56 38 16 16 0 12 0 0
Totale 360